Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/14694109

Download in:

View as

General Info

PMID
14694109